Harson Laboratories India Private Limited

Harson Laboratories India Private Limited - healthcare in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U24100GJ2016PTC086086 Incorporated 15 February 2016 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Private Limited Company healthcare MSME · Small
Data last updated
Revenue · FY 2025
₹9.71 Cr
▲ 38% YoY
Net profit · FY 2025
₹61.33 Lakh
Net margin 6.3%
EBITDA · FY 2025
₹1.85 Cr
EBITDA margin 19.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.9 Cr
Issued & subscribed
Open charges
₹90.51 Lakh
Satisfied ₹21 Cr
Company age
10 yrs
Est. 2016
Employees · EPFO
34
Provident fund records

About Harson Laboratories India Private Limited

Data last updated:

Harson Laboratories India Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 15 February 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2016PTC086086. Its GSTIN is 24AADCH8721R1Z3 (Gujarat).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.9 Cr. It is led by directors including Bhavesh Chandulal Vora and Divyesh Chandulal Vora.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R S No. 361/P1 Dabhasa Padra, Vadodara, Gujarat, India – 391440.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.71 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹61.33 Lakh (net margin 6.3%) and EBITDA of ₹1.85 Cr (EBITDA margin 19.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 39% over five years.

The company has about 34 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Harson Laboratories. As per MCA filings, the company has open charges of ₹90.51 Lakh and satisfied charges of ₹21 Cr on record. The company has 2 deals on record (2 rights issues); the latest was in January 2019. Its 4 peer companies in the Healthcare industry (Formulations, Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Mcneil and Argus Pharmaceuticals Limited with revenue of ₹9.73 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 179 overdue payments to 40 micro and small suppliers.

Harson Laboratories India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0007366). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website harsonlab.com.

Company details

CIN U24100GJ2016PTC086086
Registration Number 086086
Incorporation Date 15 February 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0007366
Key People
Bhavesh Chandulal Vora Director Divyesh Chandulal Vora Director Jayesh Chandulal Vora Director

Recognitions & Rankings of Harson Laboratories India

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-24-0007366

Contact details

Harson Laboratories India Private Limited's registered office is in Vadodara, Gujarat. Its website is harsonlab.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    harsonlab.com
  • Registered Address
    R S No. 361/P1 Dabhasa Padra, Vadodara, Gujarat, India – 391440
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Harson Laboratories India Private Limited, buy the company report.

Comprehensive company report
Harson Laboratories India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Harson Laboratories India operates one associated brand: Harson Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Harson Laboratories
Manufacturing and supplying pharmaceutical injections with a focus on quality and innovation.harsonlab.com

Business activity

The main business activities of Harson Laboratories India are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Harson Laboratories India Private Limited, buy the company report.

Financials of Harson Laboratories India Private Limited

FY 2025 filings available

Harson Laboratories India Private Limited reported revenue of ₹9.71 Cr (up 38% YoY) for FY 2025.

Revenue · FY 2025
₹9.71 Cr ▲ 38%
Net profit · FY 2025
₹61.33 Lakh margin 6.3%
EBITDA · FY 2025
₹1.85 Cr margin 19.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 7%
5 years · compounded
▲ 39%
EBITDA CAGR growth
3 years · compounded
▼ 20%
5 years · compounded
▲ 27%

Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 38% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.85 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹61.33 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.1%
Net Profit Margin6.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Harson Laboratories India Private Limited, buy the company report.

Board of directors of Harson Laboratories India Private Limited

Harson Laboratories India has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhavesh Chandulal Vora
Also directs: Harson Labs Pvt Ltd
Director15 Feb 201610 Years 8 MonthsCurrent
Divyesh Chandulal Vora
Also directs: Harson Labs Pvt Ltd
Director15 Feb 201610 Years 8 MonthsCurrent
Jayesh Chandulal Vora
Also directs: Harson Labs Pvt Ltd
Director15 Feb 201610 Years 8 MonthsCurrent
View all directors

Peer comparison

Harson Laboratories India Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Formulations, Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mcneil and Argus Pharmaceuticals Limited₹9.73 Cr (FY 2024)-59.0%Haryana, India
Labinduss Limited₹9.73 Cr (FY 2025)27.0%Palghat, Kerala, India
Harson Laboratories India Private Limitedthis company₹9.71 Cr (FY 2025)₹61.33 Lakh6.3%38.0%34Vadodara, Gujarat, India
Chevron Pharma Private Limited₹9.69 Cr (FY 2025)33.0%Ankleshwar, Gujarat, India
Uni-Labs (India) Private Limited₹9.68 Cr (FY 2024)-8.0%Tamil Nadu, India

To see the full peer comparison of Harson Laboratories India Private Limited, buy the company report.

Auditor

Harson Laboratories India Private Limited is audited by SHAH SANGHVI & CO. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
SHAH SANGHVI & CO.FY 2022109794W

Shareholding

The shareholding of Harson Laboratories India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Harson Laboratories India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹90.51 Lakh
Satisfied charges
₹21 Cr
Breakdown by lending institutions
Sidbi₹0.91 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Sep 2024100996289Sidbi₹90.51 LakhOpen
27 Dec 2017100147490Others₹10.5 CrSatisfied
04 Dec 2017100142864Others₹10.5 CrSatisfied

To see the full charge records of Harson Laboratories India Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Harson Laboratories India Private Limited has 2 deals on record (2 rights issues); the latest was in January 2019.

Total deals
2
Rights issues
2

Deals on record (2 of 2)

WhenDealAmountParties
Jan 2019Rights issue₹1.64 CrInvestors: 3 individuals
Dec 2017Rights issue₹2.25 CrInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Harson Laboratories India Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 179 overdue payments to 40 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 40)

SupplierAmount dueDue sinceReported on
Instant Label Mfg Co
an individual supplier
Siddhambika Impex
Hutaib Storage Systems
an individual supplier

To see the full MSME payment records of Harson Laboratories India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Harson Laboratories India Private Limited has a workforce of 34 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
34
Active EPFO establishments
1
Employee growth
9.68%

GST

Harson Laboratories India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AADCH8721R1Z3GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Harson Laboratories India Private Limited, buy the company report.

Recent activity

Harson Laboratories India Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Bhavesh Chandulal Vora was appointed as Director on 15 Feb 2016.

AGM
Harson Laboratories India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Harson Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Sidbi amounted to Rs. 0.91 Cr with Charge ID 100996289 was registered on 30 Sep 2024.
Charges
A charge registered on 27 Dec 2017 via Charge ID 100147490 with Others was fully satisfied on 28 May 2024.
Charges
A charge registered on 04 Dec 2017 via Charge ID 100142864 with Others was fully satisfied on 28 May 2024.
Charges
A charge with Others of Rs. 10.50 Cr registered on 27 Dec 2017 with Charge ID 100147490 was modified on 28 Mar 2021.
Charges
A charge with Others of Rs. 10.50 Cr registered on 04 Dec 2017 with Charge ID 100142864 was modified on 12 Mar 2021.
Charges
A charge with Others amounted to Rs. 10.50 Cr with Charge ID 100147490 was registered on 27 Dec 2017.
Charges
A charge with Others amounted to Rs. 10.50 Cr with Charge ID 100142864 was registered on 04 Dec 2017.
Appointed
Bhavesh Chandulal Vora was appointed as Director.
Appointed
Divyesh Chandulal Vora was appointed as Director.
Appointed
Jayesh Chandulal Vora was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Harson Laboratories India is an active private limited company based in Vadodara, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 15 February 2016 (10+ years old) and is registered under CIN U24100GJ2016PTC086086.

Harson Laboratories India has 3 current directors:

The latest financial statements of Harson Laboratories India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Harson Laboratories India is 24AADCH8721R1Z3, registered in Gujarat.

The CIN (Corporate Identification Number) of Harson Laboratories India is U24100GJ2016PTC086086. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Harson Laboratories India was incorporated on 15 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Harson Laboratories India has 2 deals on record (2 rights issues); the latest was in January 2019.

The peers of Harson Laboratories India by revenue are Mcneil and Argus Pharmaceuticals Limited, Labinduss Limited, Chevron Pharma Private Limited, Uni-Labs (India) Private Limited, all in the Healthcare industry (Formulations, Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bhavesh Chandulal Vora was appointed as Director on 15 Feb 2016. Divyesh Chandulal Vora was appointed as Director on 15 Feb 2016. Jayesh Chandulal Vora was appointed as Director on 15 Feb 2016.

Yes, Harson Laboratories India is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0007366).

Harson Laboratories India has 11 MSME Form 1 returns on record between 2019 and 2023, listing 179 overdue payments to 40 micro and small suppliers. The latest return was filed on 28 Aug 2023.

Harson Laboratories India can be reached through the website harsonlab.com. Its registered office is in Vadodara, Gujarat, India.